251 related articles for article (PubMed ID: 16628258)
1. A single-pill combination of amlodipine besylate and atorvastatin calcium.
Blank R
Drugs Today (Barc); 2006 Mar; 42(3):157-75. PubMed ID: 16628258
[TBL] [Abstract][Full Text] [Related]
2. A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
Blank R; Hobbs FD; Zamorano J; Girerd X
Drugs Today (Barc); 2007 Mar; 43(3):157-77. PubMed ID: 17380213
[TBL] [Abstract][Full Text] [Related]
3. Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
Hobbs FD; Gensini G; Mancini GB; Manolis AJ; Bauer B; Böhler S; Genest J; Feldman R; Harvey P; Jenssen TG; Metcalfe M; da Silva PM;
Int J Cardiol; 2006 Jun; 110(2):242-50. PubMed ID: 16338012
[TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial.
Preston RA; Harvey P; Herfert O; Dykstra G; Jukema JW; Sun F; Gillen D
J Clin Pharmacol; 2007 Dec; 47(12):1555-69. PubMed ID: 18048574
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin calcium plus amlodipine for the treatment of hypertension.
Delgado-Montero A; Zamorano JL
Expert Opin Pharmacother; 2012 Dec; 13(18):2673-85. PubMed ID: 23140185
[TBL] [Abstract][Full Text] [Related]
6. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
McKeage K; Siddiqui MA
Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
[TBL] [Abstract][Full Text] [Related]
7. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
[TBL] [Abstract][Full Text] [Related]
8. Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives.
Devabhaktuni M; Bangalore S
Vasc Health Risk Manag; 2009; 5(1):377-87. PubMed ID: 19475775
[TBL] [Abstract][Full Text] [Related]
9. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
Curran MP
Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
[TBL] [Abstract][Full Text] [Related]
10. Fixed combination of amlodipine/atorvastatin: from mechanisms to trials.
Ivanovic B; Tadic M
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):544-9. PubMed ID: 23832643
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.
Cowie MR
Int J Clin Pract; 2005 Jul; 59(7):839-46. PubMed ID: 15963213
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial.
Grimm R; Malik M; Yunis C; Sutradhar S; Kursun A;
Vasc Health Risk Manag; 2010 May; 6():261-71. PubMed ID: 20479948
[TBL] [Abstract][Full Text] [Related]
13. Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients.
Derosa G; Maffioli P
Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):835-43. PubMed ID: 20528641
[TBL] [Abstract][Full Text] [Related]
14. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
Richard Hobbs FD; Gensini G; John Mancini GB; Manolis AJ; Bauer B; Genest J; Feldman RD; Harvey P; Jenssen TG; da Silva PM;
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658
[TBL] [Abstract][Full Text] [Related]
15. Slovak trial on cardiovascular risk reduction following national guidelines with CaDUET® (the STRONG DUET study).
Fedacko J; Pella D; Jarcuska P; Sabol F; Kmec J; Lopuchovsky T; Merkovska L; Jedlickova L; Janicko M; Sajty M
Adv Ther; 2013 Jan; 30(1):60-70. PubMed ID: 23328937
[TBL] [Abstract][Full Text] [Related]
16. Effect of food on the bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.
Chung M; Calcagni A; Glue P; Bramson C
J Clin Pharmacol; 2006 Oct; 46(10):1212-6. PubMed ID: 16988211
[No Abstract] [Full Text] [Related]
17. Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis.
Cho EJ; Kim JH; Sutradhar S; Yunis C; Westergaard M;
Vasc Health Risk Manag; 2014; 10():145-56. PubMed ID: 24707184
[TBL] [Abstract][Full Text] [Related]
18. Predicted coronary heart disease risk reduction and dual blood pressure/cholesterol goal attainment in patients with hypertension treated in real-world clinical practice.
Neutel JM; Eaddy M; Lunacsek OE; Roberts C; Chen L; Kean AJ; Jackson JH
J Clin Hypertens (Greenwich); 2010 Jun; 12(6):396-406. PubMed ID: 20591084
[TBL] [Abstract][Full Text] [Related]
19. Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients.
Martín-Ventura JL; Tuñon J; Duran MC; Blanco-Colio LM; Vivanco F; Egido J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S189-93. PubMed ID: 17130260
[TBL] [Abstract][Full Text] [Related]
20. EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA.
Naydenov Naydenov S; Margaritov Runev N; Ivanov Manov E; Georgieva Torbova-Gigova S
Acta Clin Croat; 2018 Sep; 57(3):464-472. PubMed ID: 31168179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]